"Clinical Trials as Topic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries.
| Descriptor ID |
D002986
|
| MeSH Number(s) |
E05.318.760.250.500 N05.715.360.775.088.500 N06.850.520.450.250.250
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Clinical Trials as Topic".
Below are MeSH descriptors whose meaning is more specific than "Clinical Trials as Topic".
This graph shows the total number of publications written about "Clinical Trials as Topic" by people in this website by year, and whether "Clinical Trials as Topic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 2 | 2 |
| 1996 | 0 | 3 | 3 |
| 1999 | 0 | 1 | 1 |
| 2000 | 0 | 2 | 2 |
| 2001 | 0 | 2 | 2 |
| 2002 | 0 | 1 | 1 |
| 2003 | 2 | 2 | 4 |
| 2004 | 0 | 5 | 5 |
| 2005 | 1 | 3 | 4 |
| 2006 | 2 | 3 | 5 |
| 2007 | 2 | 3 | 5 |
| 2008 | 0 | 2 | 2 |
| 2009 | 1 | 6 | 7 |
| 2010 | 4 | 2 | 6 |
| 2011 | 1 | 4 | 5 |
| 2012 | 4 | 3 | 7 |
| 2013 | 4 | 4 | 8 |
| 2014 | 6 | 2 | 8 |
| 2015 | 4 | 5 | 9 |
| 2016 | 3 | 7 | 10 |
| 2017 | 4 | 4 | 8 |
| 2018 | 2 | 6 | 8 |
| 2019 | 8 | 4 | 12 |
| 2020 | 1 | 9 | 10 |
| 2021 | 3 | 4 | 7 |
| 2022 | 0 | 5 | 5 |
| 2023 | 1 | 3 | 4 |
| 2024 | 0 | 6 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Clinical Trials as Topic" by people in Profiles.
-
Optimization of Timing for Risk-Reducing Salpingectomy and Oophorectomy. Obstet Gynecol. 2025 Jan 01; 145(1):21-30.
-
Safety and tolerability of mirvetuximab soravtansine monotherapy for folate receptor alpha-expressing recurrent ovarian cancer: An integrated safety summary. Gynecol Oncol. 2024 Dec; 191:249-258.
-
Financial toxicity in early-phase cancer clinical trial participants. Cancer. 2025 Jan 01; 131(1):e35586.
-
Establishing Consensus for Mohs Micrographic Surgical Techniques in the Treatment of Melanoma in Situ for Future Clinical Trials: A Modified Delphi Study. J Natl Compr Canc Netw. 2024 07 30; 22(8).
-
Time Toxicity Experienced by Early-Phase Cancer Clinical Trial Participants. JCO Oncol Pract. 2024 Sep; 20(9):1252-1262.
-
A Hard Truth to Swallow: Critically Evaluating the MD Anderson Dysphagia Inventory (MDADI) as an Endpoint in Human Papillomavirus-associated Oropharyngeal Cancer Trials. Int J Radiat Oncol Biol Phys. 2024 Nov 01; 120(3):805-822.
-
Patient-Reported Outcomes in Clinical Trials: From an Endpoint to an Intervention in Cancer Care. Semin Radiat Oncol. 2023 10; 33(4):358-366.
-
An evaluation of reporting guidelines and Clinical Trial Registry requirements among anesthesiology journals. J Evid Based Med. 2023 06; 16(2):116-119.
-
Identifying Early-Phase Clinical Trial Participants at Risk for Experiencing Worse Clinical Outcomes. JCO Oncol Pract. 2023 06; 19(6):e829-e837.
-
Update on the Efficacy and Safety Profile of Voclosporin: An Integrated Analysis of Clinical Trials in Lupus Nephritis. Arthritis Care Res (Hoboken). 2023 07; 75(7):1399-1408.